O anti‐CCP não é um marcador de gravidade da artrite reumatoide estabelecida: um estudo de ressonância magnética

ResumoIntroduçãoA presença do anti‐CCP constitui importante ferramenta prognóstica da artrite reumatoide (AR), mas ainda se investiga sua relação com a atividade da doença e a a capacidade funcional.ObjetivosEstudar a relação do anti‐CCP com os índices de atividade da doença, de capacidade funcional e de dano estrutural, por meio de radiografia convencional (RC) e de ressonância magnética (RM), em AR estabelecida.MétodosEstudo transversal com pacientes com AR, com um a 10 anos de doença. Os participantes foram submetidos à avaliação clínica com pesquisa do anti‐CCP. A atividade de doença foi avaliada por meio do Clinical Disease Activity Index (CDAI) e a capacidade funcional por meio do Health Assessment Questionnaire (HAQ). A análise da RC foi feita pelo índice de Sharp van der Heijde (SmvH) e da RM pelo Sistema de Pontuação de Imagem por Ressonância Magnética na Artrite Reumatoide (RAMRIS, Rheumatoid Arthritis Magnetic Resonance Image Scoring).ResultadosForam avaliados 56 pacientes, com mediana (IIq) de 55 (47,5‐60,0) anos, 50 (89,3%) do sexo feminino e 37 (66,1%) anti‐CCP positivos. As medianas (IIq) do CDAI, do HAQ, de SmvH e do RAMRIS foram de 14,75 (5,42‐24,97), 1,06 (0,28‐1,75), 2 (0‐8) e 15 (7‐35), respectivamente. Não houve associação do anti‐CCP com o CDAI, com o HAQ e com os escores SmvH e RAMRIS.ConclusãoNossos resultados não estabeleceram a associação do anti‐CCP com a gravidade da doença. Até o momento, não podemos corroborar o anti‐CCP como uma ferramenta prognóstica em AR estabelecida.AbstractIntroductionThe presence of anti‐CCP is an important prognostic tool of rheumatoid arthritis (RA). But research is still ongoing on its relationship with disease activity and functional capacity.ObjectivesTo study the relationship between anti‐CCP and disease activity, functional capacity and structural damage indexes, by means of conventional radiography (CR) and magnetic resonance imaging (MRI), in cases of established RA.MethodsCross‐sectional study with RA patients with 1‐10 years of disease duration. Participants underwent clinical evaluation with anti‐CCP. Disease activity was assessed using the Clinical Disease Activity Index (CDAI), and functional capacity through the Health Assessment Questionnaire (HAQ). CR analysis was carried out by the Sharp van der Heijde index (SvdH), and MRI analysis by RAMRIS (Rheumatoid Arthritis Magnetic Resonance Image Scoring).ResultsWe evaluated 56 patients, with a median (IqR) age of 55 (47.5‐60.0) years; 50 (89.3%) participants were female and 37 (66.1%) were positive for anti‐CCP. Medians (IqR) of CDAI, HAQ, SvdH and RAMRIS were 14.75 (5.42‐24.97) 1.06 (0.28‐1.75), 2 (0‐8) and 15 (7‐35), respectively. There was no association between anti‐CCP and CDAI, HAQ and SvdH and RAMRIS scores.ConclusionOur results have not established an association of anti‐CCP with the severity of disease. To date, we cannot corroborate anti‐CCP as a prognostic tool in patients with established RA

Anti-CCP antibodies are not a marker of severity in established rheumatoid arthritis: a magnetic resonance imaging study

ABSTRACT Introduction: The presence of anti-CCP is an important prognostic tool of rheumatoid arthritis (RA). But research is still ongoing on its relationship with disease activity and functional capacity. Objectives: To study the relationship between anti-CCP and disease activity, functional capacity and structural damage indexes, by means of conventional radiography (CR) and magnetic resonance imaging (MRI), in cases of established RA. Methods: Cross-sectional study with RA patients with 1–10 disease duration. Participants underwent clinical evaluation with anti-CCP. Disease activity was assessed using the Clinical Disease Activity Index (CDAI), and functional capacity through the Health Assessment Questionnaire (HAQ). CR analysis was carried out by the Sharp van der Heijde index (SvdH), and MRI analysis by RAMRIS (Rheumatoid Arthritis Magnetic Resonance Image Scoring). Results: We evaluated 56 patients, with a median (IqR) age of 55 (47.5–60) years; 50 (89.3%) participants were female and 37 (66.1%) were positive for anti-CCP. Medians (IqR) of CDAI, HAQ, SvdH and RAMRIS were 14.75 (5.42–24.97) 1.06 (0.28–1.75), 2 (0–8) and 15 (7–35), respectively. There was no association between anti-CCP and CDAI, HAQ and SvdH and RAMRIS scores. Conclusion: Our results have not established an association of anti-CCP with the severity of disease. To date, we cannot corroborate anti-CCP as a prognostic tool in patients with established RA